Eli Lilly came to the 44 th annual JP Morgan Healthcare Conference bolstered by a strong year. 1 While the looming patent cliff still impacts that company’s upcoming strategy, Lilly found itself in a ...

"The guiding principles of good AI practice in drug development are a first step of a renewed EU-US cooperation... to ...

See which markets will be strong in 2026 — and which surprise areas that are ripe for electrical construction work.

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

These three AI ETFs have been successful in the past, and have underperformed the market in the last month. If they return to their normal growth, investors will see huge returns. 10 stocks we like ...

Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the ...